Endonovo Therapeutics Announces Second Quarter Results
August 13, 2019 13:39 ET
|
Endonovo Therapeutics Inc.
LOS ANGELES, Aug. 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire – Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), today announces financial and operating results for the...
Endonovo Therapeutics Announces National Rollout of SofPulse® Post-Operative Opioid Alternative into Hospitals
June 13, 2019 08:30 ET
|
Endonovo Therapeutics Inc.
WOODLAND HILLS, Calif., June 13, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive...
Coverage Initiated for Endonovo Therapeutics via NetworkNewsWire
May 29, 2019 08:30 ET
|
Endonovo Therapeutics Inc.
NEW YORK, May 29, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company developing a bioelectronic approach to regenerative medicine,...